ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-1,198 Cr | ₹-1,068 Cr | ₹-942 Cr | ₹-955 Cr | ₹-643 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-1,198 Cr |
Mar2023 | ₹-1,068 Cr |
Mar2022 | ₹-942 Cr |
Mar2021 | ₹-955 Cr |
Mar2020 | ₹-643 Cr |
How is Deferred Tax Assets / Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-1,198 Cr | Negative | |
Mar2023 | ₹-1,068 Cr | Negative | |
Mar2022 | ₹-942 Cr | Negative | |
Mar2021 | ₹-955 Cr | Negative | |
Mar2020 | ₹-643 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹88,294.1 Cr | -3.3% | -1% | -11.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,155.0 Cr | -3.9% | 3% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,295.0 Cr | -5% | -1.1% | 71.6% | Stock Analytics | |
CIPLA | ₹116,664.0 Cr | -4.4% | 0.2% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,678.0 Cr | -1.6% | 6.5% | 26.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,162.6 Cr | -2.4% | 2.4% | -5.4% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -3.3% |
-1% |
-11.4% |
SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses